In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp

Najafzadeh, M. J. and Badali, H. and Illnait-Zaragozi, M. T. and De Hoog, G. S. and Meis, J. F. (2010) In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrobial Agents and Chemotherapy, 54 (4). pp. 1636-1638.

[img] Text
Antimicrobial Agents and Chemotherapy-2010-Najafzadeh-1636.full.pdf

Download (50kB)

Abstract

The in vitro activities of eight antifungal drugs against clinical isolates of Fonsecaea pedrosoi (n = 21), Fonsecaea monophora (n = 25), and Fonsecaea nubica (n = 9) were tested. The resulting MIC90s for all strains (n = 55) were as follows, in increasing order: posaconazole, 0.063 μg/ml; itraconazole, 0.125 μg/ml; isavuconazole, 0.25 μg/ml; voriconazole, 0.5 μg/ml; amphotericin B, 2 μg/ml; caspofungin, 2 μg/ml; anidulafungin, 2 μg/ml; and fluconazole, 32 μg/ml. Copyright © 2010, American Society for Microbiology. All Rights Reserved.

Item Type: Article
Additional Information: Cited By :45 Export Date: 16 February 2020 CODEN: AMACC Correspondence Address: Meis, J. F.; Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen 6500, Netherlands; email: j.meis@cwz.nl
Uncontrolled Keywords: amphotericin B anidulafungin caspofungin fluconazole isavuconazole itraconazole posaconazole voriconazole antifungal activity article drug sensitivity Fonsecaea Fonsecaea monophora Fonsecaea nubica Fonsecaea pedrosoi minimum inhibitory concentration nonhuman priority journal Antifungal Agents Ascomycota Chromoblastomycosis Drug Resistance, Fungal Echinocandins Humans Microbial Sensitivity Tests Nitriles Pyridines Pyrimidines Triazoles
Subjects: QY Clinical Pathology
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib4 lib4
Date Deposited: 01 Mar 2020 07:12
Last Modified: 01 Mar 2020 07:12
URI: http://eprints.mums.ac.ir/id/eprint/13120

Actions (login required)

View Item View Item